The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2024

Filed:

Mar. 11, 2022
Applicants:

Terran Biosciences Inc., New York, NY (US);

The Trustees of Columbia University IN the City of New York, New York, NY (US);

The Research Foundation for Mental Hygiene, Inc., Menands, NY (US);

Inventors:

Samuel Clark, New York, NY (US);

Kenneth Wengler, New York, NY (US);

Guillermo Horga Hernandez, New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G06T 5/50 (2006.01); A61B 5/055 (2006.01); G06T 5/90 (2024.01); G06T 7/00 (2017.01); G16H 50/20 (2018.01);
U.S. Cl.
CPC ...
G06T 5/50 (2013.01); A61B 5/055 (2013.01); G06T 5/90 (2024.01); G06T 7/0014 (2013.01); G16H 50/20 (2018.01); G06T 2207/10088 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/30016 (2013.01);
Abstract

An exemplary system, method and computer-accessible medium for harmonizing neuromelanin (NM) data using combat directly on a NM database or using combat generated coefficients to harmonize future data can include, for example, receiving imaging information of a brain of the patient(s), from one MRI scanner, receiving imaging information of a brain of the patient(s), from a second MRI scanner and using combat to harmonize the data between scanners against a reference dataset. The Neuromelanin (NM) concentration of the patient(s) can then be determined based on the harmonized data. The NM concentration can be determined using a voxel-wise analysis procedure. The voxel-wise analysis procedure can be used to determine a topographical pattern(s) within a substantia nigra (SN) of the brain of the patient(s).


Find Patent Forward Citations

Loading…